SHELTON JERRELL

CEO Shelton Jerrell sold 339,720 shares (339.7K) for $2.3M over 3 trading days as CYRX trades 34.9% below 52-week high.

CEO Shelton Jerrell executed 3 separate sales totaling 339,720 shares (339.7K shares) for $2,289,781.35 ($2.3M) between 2025-06-17 and 2025-06-20, reducing his holdings by 27.1% to 912,419 shares (912.4K shares). The blended average sale price of $6.74 occurred while the stock trades at $6.37, currently positioned 34.9% below its 52-week high of $9.79 and within the lower half of its 52-week range ($4.70–$9.79). Cryoport remains unprofitable, with net income of $-11,981,000.00 ($-12.0M) against quarterly revenue of $41,040,000.00 ($41.0M), and faces annual revenue contraction of 2.1%. Notably, across his same-ticker history at CYRX, 4 of 5 prior sells showed negative 90-day returns (well-timed outcomes: dates 2024-11-20, 2024-11-19, 2024-11-18, 2024-03-15 second instance). The current filing merits monitoring as a concentrated divestiture by the CEO during a period of depressed valuation and operational challenges.

CYRX CEO Shelton Jerrell sells 150,000 shares for $1.0M across 3 trades under 10b5-1 plan (adopted 2024-03-15).

Shelton Jerrell, as President and CEO, executed 3 separate sales totaling 150,000 shares for $1,007,820.00 at an average price of $6.72 per share on November 18-20, 2024. His post-transaction holdings of 722,747 shares represent a 17.2% reduction from pre-transaction holdings of 872,747 shares. Critically, this transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2024-03-15, meaning the sales were scheduled rather than discretionary. As a scheduled transaction under a Rule 10b5-1 plan, this does not reflect a current trading decision or judgment about near-term stock direction.